CSF markers of neurodegeneration in Parkinson's disease

Journal of Neural Transmission

Volumn 117, Issue 10, 2010, Pages 1177-1181

  Vranová, Hana Přikrylová ^a   Mareš, Jan ^a   Nevrlý, Martin ^a   Stejskal, David ^a   Zapletalová, Jana ^a   Hluštík, Petr ^a   Kaňovský, Petr ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

Clusterin; CSF; Neurodegeneration; Parkinson's disease; Tau protein

Indexed keywords

AMYLOID BETA PROTEIN; BIOLOGICAL MARKER; CLUSTERIN; CYSTATIN C; LEVODOPA; TAU PROTEIN;

ADULT; AGED; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID EXAMINATION; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; MALE; NERVE DEGENERATION; PARKINSON DISEASE; PRIORITY JOURNAL;

ADULT; AGED; BIOLOGICAL MARKERS; CEREBROSPINAL FLUID PROTEINS; FEMALE; HUMANS; MALE; MIDDLE AGED; NERVE DEGENERATION; NERVE TISSUE PROTEINS; PARKINSON DISEASE;

EID: 78651289426     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-010-0462-z     Document Type: Article

References (22)

1. ZI Alam A Jenner SE Daniel AJ Lees N Cairns CD Marsden, et al. 1997 Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra J Neurochem 69 1196 1203 1:CAS:528:DyaK2sXls1Chtbs%3D 10.1046/j.1471-4159.1997.69031196.x 9282943
2. K Arima S Hirai N Sunohara K Aoto Y Izumiyama K Ueda, et al. 1999 Cellular colocalization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in Lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies Brain Res 843 53 61 1:CAS:528:DyaK1MXmvVGqt78%3D 10.1016/S0006-8993(99)01848-X 10528110 (Pubitemid 29488694)
3. M Bibl B Mollenhauer H Esselmann P Lewczuk HW Klafki K Sparbier A Smirnov L Cepek C Trenkwalder E Rüther J Kornhuber M Otto J Wiltfang 2006 CSF amyloid-beta-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia Brain 129 Pt 5 1177 1187 10.1093/brain/awl063 16600985 c
4. H Braak K Del Tredici U Rüb, et al. 2003 Staging of brain pathology related to sporadic Parkinson's disease Neurobiol Aging 24 197 211 10.1016/S0197-4580(02)00065-9 12498954 (Pubitemid 36007810)
5. MR Cookson M van der Brug 2008 Cell systems and the toxic mechanism(s) of alpha-synuclein Exp Neurol 209 5 11 1:CAS:528:DC%2BD1cXivFegsQ%3D%3D 10.1016/j.expneurol.2007.05.022 17603039
6. A Esposito CP Dohm P Kermer M Bähr FS Wouters 2007 alpha-Synuclein and its disease related mutants interact differentially with the microtubule protein tau and associate with the actin cytoskeleton Neurobiol Dis 26 521 531 1:CAS:528:DC%2BD2sXlsFKnsLg%3D 10.1016/j.nbd.2007.01.014 17408955 (Pubitemid 46756322)
7. AM Fagan CM Roe C Xiong MA Mintun JC Morris DM Holtzman, et al. 2007 Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults Arch Neurol 64 343 349 10.1001/archneur.64. 3.noc60123 17210801 (Pubitemid 46425688)
8. AJ Hughes SE Daniel L Kilford AJ Lees 1992 Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases J Neurol Neurosurg Psychiatry 55 181 184 1:STN:280:DyaK383is1Omsg%3D%3D 10.1136/jnnp.55.3.181 1564476
9. P Jenner CW Olanow 2006 The pathogenesis of cell death in Parkinson's disease Neurology 66 S24 S36 16717250
10. J Mareš D Stejskal J Vavrouškova K Urbánek R Herzig P Hluštík 2003 Use of cystatin C determination in clinical diagnostics Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 147 177 180 15037900
11. C Marras A Lang 2008 Invited article: changing concepts in Parkinson disease: moving beyond the decade of the brain Neurology 70 21 1996 2003 10.1212/01.wnl.0000312515.52545.51 18490620
12. KS McNaught CW Olanow 2006 Protein aggregation in the pathogenesis of familial and sporadic Parkinson's disease Neurobiol Aging 27 530 545 1:CAS:528:DC%2BD28XitVClsb8%3D 10.1016/j.neurobiolaging.2005.08.012 16207501 (Pubitemid 43290522)
13. JA Molina J Benito-Leon FJ Jimenez-Jimenez, et al. 1997 Tau protein concentrations in cerebrospinal fluid of non-demented Parkinson's disease patients Neurosci Lett 238 139 141 1:CAS:528:DyaK1cXhsFeksw%3D%3D 10.1016/S0304-3940(97)00858-6 9464639 (Pubitemid 28034342)
14. B Mollenhauer C Trenkwalder N von Ahsen M Bibl P Steinacker P Brechlin, et al. 2006 Beta-amyloid 1-42 and tau-protein in cerebrospinal fluid of patients with Parkinson's disease dementia Dement Geriatr Cogn Disord 22 3 200 208 1:CAS:528:DC%2BD28XovVeltLg%3D 10.1159/000094871 16899997 (Pubitemid 44310515)
15. S Pucci P Mazzarelli F Missiroli F Regine F Ricci 2008 Neuroprotection: VEGF, IL-6, and clusterin: the dark side of the moon Prog Brain Res 173 555 573 1:CAS:528:DC%2BD1MXmtVamsQ%3D%3D 10.1016/S0079-6123(08)01138-2 18929134
16. K Sasaki K Doh-ura Y Wakisaka T Iwaki 2002 Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies Acta Neuropathol 104 3 225 230 1:CAS:528: DC%2BD38Xls12nsbw%3D 12172907
17. AH Schapira 2008 Mitochondria in the aetiology and pathogenesis of Parkinson's disease Lancet Neurol 7 97 109 1:CAS:528:DC%2BD1cXhtlaqtbg%3D 10.1016/S1474-4422(07)70327-7 18093566 (Pubitemid 350251942)
18. D Stejskal J Vavroušková J Mareš K Urbánek 2005 Application of new laboratory marker assays in neurological diagnosis-a pilot study Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 149 2 265 266 1:CAS:528:DC%2BD28XhtFChtL7M 16601767
19. H Vranová P Kaňovský J Mareš, et al. 2008 Laboratory markers of neurodegeneration in cerebrospinal fluid and degree of motor involvement in Parkinson's disease: a correlation study Cesk Slov Neurol N 71/104 3 324 328
20. H Vranová M Nevrlý J Mareš I Nestrašil D Stejskal P Kaňovský 2009 Neurodegenerative markers in cerebrospinal fluid in Parkinson's disease Neurology 72 11 Suppl.3 66
21. D Weintraub CL Comella S Horn 2008 Parkinson's disease-part 1: pathophysiology, symptoms, burden, diagnosis, and assessment Am J Manag Care 14 2 Suppl S40 S48 18402507
22. TA Yacoubian DG Standaert 2009 Targets for Neuroprotection in Parkinson's Disease Biochim Biophys Acta 1792 7 676 687 1:CAS:528:DC%2BD1MXnsFygs7w%3D 18930814